|
NCOR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.737900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.929800E-02 |
| Normal-vs-Stage2 |
8.469900E-02 |
| Normal-vs-Stage3 |
8.35670000000066E-05 |
| Normal-vs-Stage4 |
7.214600E-04 |
| Stage1-vs-Stage2 |
9.817800E-01 |
| Stage1-vs-Stage3 |
1.346000E-02 |
| Stage1-vs-Stage4 |
5.498200E-02 |
| Stage2-vs-Stage3 |
6.985500E-02 |
| Stage2-vs-Stage4 |
1.466570E-01 |
| Stage3-vs-Stage4 |
8.204000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.343600E-03 |
| Normal-vs-AfricanAmerican |
2.456800E-01 |
| Normal-vs-Asian |
4.567600E-02 |
| Caucasian-vs-AfricanAmerican |
4.402400E-01 |
| Caucasian-vs-Asian |
8.347400E-01 |
| AfricanAmerican-vs-Asian |
6.309400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.660200E-03 |
| Normal-vs-Female |
7.699900E-03 |
| Male-vs-Female |
7.196600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.038400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.381310E-03 |
| Normal-vs-Age(61-80Yrs) |
1.241300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.879700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.468100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.864100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.217800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.104800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.255200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.431200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.659000E-03 |
| Classical-VS-Follicular |
5.490400E-02 |
| Classical-VS-Other |
4.028800E-01 |
| Classical-VS-Normal |
5.540200E-02 |
| Tall-VS-Follicular |
2.530400E-01 |
| Tall-VS-Other |
6.829600E-01 |
| Tall-VS-Normal |
3.248700E-04 |
| Follicular-VS-Other |
8.500200E-01 |
| Follicular-VS-Normal |
2.698000E-03 |
| Other-VS-Normal |
9.136100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.662700E-03 |
| Normal-vs-N1 |
3.498000E-03 |
| N0-vs-N1 |
4.152200E-01 |
|
|
